TERM ID="NYU_TERM_1" STRING="Clinical vertebral" FREQUENCY=1 START=505 END=523 LEMMA="CLINICAL VERTEBRAL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_2" STRING="Denosumab" FREQUENCY=2 START=0 END=9 LEMMA="DENOSUMAB" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_3" STRING="Denosumab" FREQUENCY=2 START=236 END=245 LEMMA="DENOSUMAB" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_4" STRING="Hip" FREQUENCY=1 START=607 END=610 LEMMA="HIP" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_5" STRING="RR" FREQUENCY=2 START=928 END=930 LEMMA="RELATIVE RISK" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_6" STRING="RR" FREQUENCY=2 START=1028 END=1030 LEMMA="RELATIVE RISK" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_7" STRING="Zoledronate" FREQUENCY=1 START=962 END=973 LEMMA="ZOLEDRONATE" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_8" STRING="administration" FREQUENCY=1 START=1204 END=1218 LEMMA="ADMINISTRATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_9" STRING="clinical vertebral" FREQUENCY=1 START=434 END=452 LEMMA="CLINICAL VERTEBRAL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_10" STRING="clinical vertebral fractures" FREQUENCY=1 START=883 END=911 LEMMA="CLINICAL VERTEBRAL FRACTURE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_11" STRING="comparator" FREQUENCY=1 START=1086 END=1096 LEMMA="COMPARATOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_12" STRING="control subjects" FREQUENCY=1 START=589 END=605 LEMMA="CONTROL SUBJECT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_13" STRING="denosumab" FREQUENCY=4 START=156 END=165 LEMMA="DENOSUMAB" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_14" STRING="denosumab" FREQUENCY=4 START=567 END=576 LEMMA="DENOSUMAB" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_15" STRING="denosumab" FREQUENCY=4 START=670 END=679 LEMMA="DENOSUMAB" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_16" STRING="denosumab" FREQUENCY=4 START=1133 END=1142 LEMMA="DENOSUMAB" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_17" STRING="evidence review group" FREQUENCY=1 START=116 END=137 LEMMA="EVIDENCE REVIEW GROUP" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_18" STRING="oral bisphosphonates" FREQUENCY=1 START=730 END=750 LEMMA="ORAL BISPHOSPHONATE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_19" STRING="osteoporotic fractures" FREQUENCY=3 START=32 END=54 LEMMA="OSTEOPOROTIC FRACTURE" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_20" STRING="osteoporotic fractures" FREQUENCY=3 START=188 END=210 LEMMA="OSTEOPOROTIC FRACTURE" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_21" STRING="osteoporotic fractures" FREQUENCY=3 START=316 END=338 LEMMA="OSTEOPOROTIC FRACTURE" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_22" STRING="postmenopausal women" FREQUENCY=2 START=58 END=78 LEMMA="POSTMENOPAUSAL WOMAN" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_23" STRING="postmenopausal women" FREQUENCY=2 START=214 END=234 LEMMA="POSTMENOPAUSAL WOMAN" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_24" STRING="randomised trial" FREQUENCY=1 START=272 END=288 LEMMA="RANDOMISED TRIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_25" STRING="relative cost-effectiveness" FREQUENCY=1 START=1102 END=1129 LEMMA="RELATIVE COST-EFFECTIVENESS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_26" STRING="relative cost-effectiveness of denosumab" FREQUENCY=1 START=1102 END=1142 LEMMA="DENOSUMAB RELATIVE COST-EFFECTIVENESS" LEMMA_FREQUENCY=1 HEAD_TERM="relative cost-effectiveness" HEAD_LEMMA="RELATIVE COST-EFFECTIVENESS"
TERM ID="NYU_TERM_27" STRING="relative risk" FREQUENCY=1 START=913 END=926 LEMMA="RELATIVE RISK" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_28" STRING="relative risks" FREQUENCY=1 START=416 END=430 LEMMA="RELATIVE RISK" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_29" STRING="relative risks of clinical vertebral" FREQUENCY=1 START=416 END=452 LEMMA="CLINICAL VERTEBRAL RELATIVE RISK" LEMMA_FREQUENCY=1 HEAD_TERM="relative risks" HEAD_LEMMA="RELATIVE RISK"
TERM ID="NYU_TERM_30" STRING="strontium ranelate" FREQUENCY=1 START=792 END=810 LEMMA="STRONTIUM RANELATE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_31" STRING="zoledronate" FREQUENCY=3 START=815 END=826 LEMMA="ZOLEDRONATE" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_32" STRING="zoledronate" FREQUENCY=3 START=1061 END=1072 LEMMA="ZOLEDRONATE" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_33" STRING="zoledronate" FREQUENCY=3 START=1147 END=1158 LEMMA="ZOLEDRONATE" LEMMA_FREQUENCY=4
